Testing a Smart Medication Dispenser (Mobili®) to Help People With Chronic Conditions Take Their Medicine

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLusofona University

About this trial

Medication adherence is one of the biggest challenges faced by healthcare systems, especially among people with multiple chronic diseases who take several medications daily. Studies show that up to half of patients do not take their medication as prescribed, which can compromise treatment effectiveness, increase complications, and lead to waste of healthcare resources.

In this context, several solutions have been developed to help patients organize their therapy, such as dose administration aids (DAAs) used in pharmacies. However, many of these systems are manual, inflexible, or difficult to use.

This study is part of the MobiMAd@PT project, which will evaluate Mobili®, a portable digital medication dispenser developed in Norway. Mobili® allows patients to automatically receive the right medication at the right time and comes with a real-time monitoring system, enabling healthcare professionals to detect missed doses and provide timely support.

The main goal of this study is to assess the effectiveness of Mobili® in improving medication adherence among patients with polypharmacy in Portugal and to understand whether this type of technology can be useful and applicable in the context of Portuguese community pharmacies. Your participation will contribute to the development of new ways to manage health at home, with the support of pharmacists and technology.

Eligibility criteria

Qualifiers

Aged 18 years and above

Non-institutionalized diabetes and cardiovascular disease patients

At least two medications in the therapeutic regimen

Requiring only regular oral medication that can be dispensed in the eDosette

Disqualifiers

Cognitive impairments preventing independent use of Mobili®

Patients using medicines that do not fit or are incompatible with being dispensed in the eDosette (i.e. some capsules, solutions, insulins or GLP-1 analogues, transdermal patches, eye-drops)

One participant per household

Trial design

Treatments tested in this trial

  • Independent use of the Mobili® Device by patients, overseen by pharmacists

Treatment groups

96 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Lusofona University

Lead sponsor

Universidade Lusófona de Humanidades e Tecnologias

Sponsor institution

CBIOS - Research Center for Biosciences & Health Technologies

Collaborator

MedThings

Collaborator

Associação Nacional das Farmácias

Collaborator

University of Oslo

Collaborator

Universidade de Trás-os-Montes e Alto Douro

Collaborator

GHTM - Global Health and Tropical Medicine

Collaborator

COFAC Cooperativa de Formacao e Animacao Cultural CRL (Portugal)

Collaborator